Data / Research funding / California / San Diego Biomedical Research Institute
San Diego Biomedical Research Institute: 24 NIH awards ($31.4M), fiscal years 2021 to 2026
San Diego Biomedical Research Institute in San Diego, CA is funded under 24 NIH awards ($31.4M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- ZM3DYHAGMKM3
- State
- California
Awards
24 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,133,062 | March 1, 2011 | May 31, 2025 | BINLEY, JAMES M | reporter.nih.gov |
| The protective role of microglia in preventing hypoxic disruption of blood-brain barrier integrity and VCID | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,224,569 | February 15, 2021 | January 31, 2024 | MILNER, D. RICHARD | reporter.nih.gov |
| Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,115,803 | May 1, 2021 | April 30, 2026 | BACCALA, ROBERTO G | reporter.nih.gov |
| Oncogenic pathway-induced fragile sites: a new paradigm for understanding genome instability in cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,097,597 | March 10, 2022 | February 28, 2027 | GILBERT, DAVID M | reporter.nih.gov |
| HIV antibodies and NK cell ADCC: nanometer-scale tracking of immune synapse dynamics. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,774,750 | September 17, 2021 | February 28, 2027 | MURIN, CHARLES DANIEL | reporter.nih.gov |
| Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,588,360 | August 15, 2024 | May 31, 2029 | MARCONDES, MARIA CECILIA GARIBALDI | reporter.nih.gov |
| cis-Acting Elements Regulating Developmental Control of Replication Timing | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,491,988 | September 30, 2007 | August 31, 2029 | GILBERT, DAVID M | reporter.nih.gov |
| Anti-inflammatory signals and neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,467,006 | September 1, 2024 | June 30, 2028 | CONTI, BRUNO | reporter.nih.gov |
| IdeNtifying reSponse defIninG mecHanisms for biological TherapieS in SevereAsthma (INSIGHTS ); assessing the role of CD4-CTLs | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,436,586 | September 20, 2025 | June 30, 2027 | SEUMOIS, GREGORY | reporter.nih.gov |
| The protective role of microglia in preventing hypoxic disruption of blood-brain barrier integrity and VCID | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,423,377 | February 15, 2021 | January 31, 2027 | MILNER, D. RICHARD | reporter.nih.gov |
| Molecular mechanisms of autophagosome biogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,356,209 | December 1, 2010 | March 31, 2025 | OTOMO, TAKANORI | reporter.nih.gov |
| Dopamine system as reporter of HIV status and inflammation in Meth abusers | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,302,264 | February 1, 2019 | January 31, 2025 | MARCONDES, MARIA CECILIA GARIBALDI | reporter.nih.gov |
| Evaluating the therapeutic potential of hypoxia mimetics in inflammatory demyelinating disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,302,208 | August 1, 2024 | June 30, 2029 | MILNER, D. RICHARD | reporter.nih.gov |
| Methamphetamine, HIV integration and latency in the brain | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,175,173 | September 30, 2023 | August 31, 2025 | MARCONDES, MARIA CECILIA GARIBALDI | reporter.nih.gov |
| Mapping the 3D architecture of native human replisomes | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,152,299 | August 2, 2019 | May 31, 2024 | GILBERT, DAVID M | reporter.nih.gov |
| Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $980,417 | September 20, 2022 | July 31, 2027 | SEUMOIS, GREGORY | reporter.nih.gov |
| A vasculo-protective role for beta4 integrin in neuroinflammation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $840,000 | December 1, 2018 | February 29, 2024 | MILNER, D. RICHARD | reporter.nih.gov |
| Methamphetamine, HIV integration and latency in the brain | NIH | National Institute on Drug Abuse | 2025 | $798,422 | September 30, 2023 | August 31, 2028 | MARCONDES, MARIA CECILIA GARIBALDI | reporter.nih.gov |
| Anti-inflammatory signals and neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $646,104 | September 21, 2023 | August 31, 2025 | CONTI, BRUNO | reporter.nih.gov |
| Autoimmunity, calorie restriction, and core body temperature | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $541,500 | June 17, 2025 | May 31, 2027 | BACCALA, ROBERTO G | reporter.nih.gov |
| Calorie Restriction, Body Temperature and Alzheimers Disease | NIH | National Institute on Aging | 2023 to 2024 | $536,250 | September 1, 2023 | May 31, 2026 | CONTI, BRUNO | reporter.nih.gov |
| Differential role of TASL and SLC15A4 in TLR responses to nucleic acids and lupus development | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $528,000 | November 18, 2022 | October 31, 2025 | BACCALA, ROBERTO G | reporter.nih.gov |
| Do allergens contribute to neurodegeneration? | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $221,875 | May 16, 2022 | March 31, 2023 | CONTI, BRUNO | reporter.nih.gov |
| A novel CD4+ T cell subset associated with allergy protection | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $217,111 | July 11, 2023 | June 30, 2026 | SEUMOIS, GREGORY | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 11 | $7,608,117 | 0 | $0 |
| 2024 | 13 | $7,069,526 | 0 | $0 |
| 2023 | 11 | $5,670,155 | 0 | $0 |
| 2022 | 9 | $4,956,322 | 0 | $0 |
| 2021 | 9 | $6,046,810 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Brain Disorders
- Neurosciences
- Genetics
- Infectious Diseases
- Neurodegenerative
- Human Genome
- Biotechnology
- HIV/AIDS
- Autoimmune Disease
- Prevention
- Cerebrovascular
- Aging
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.